{
  "links": "https://www.ycombinator.com/companies/talus-bio",
  "name": "Talus Bio",
  "headline": "Discovering drugs that target the DNA regulome",
  "batch": "S21",
  "description": "We have built a platform that enables drug discovery and development for previously undruggable genome regulators (\"the regulome\"). We accomplish this by moving drug discovery out of artificial systems where regulome proteins fail to function properly, and back into live human cells. Our technology combines innovations in automated cell processing, next-gen proteomics, and advanced data analytics to measure a drug's effect on the entire regulome in one experiment.",
  "activity_status": "Active",
  "website": "https://www.talus.bio",
  "founded_date": 2020.0,
  "team_size": 16.0,
  "location": "Seattle, WA",
  "group_partner": "Jared Friedman",
  "group_partner_yc": "https://www.ycombinator.com/people/jared-friedman",
  "company_linkedin": null,
  "company_twitter": null,
  "tags": "industry:biotech; industry:genomics; industry:drug-discovery; location:seattle",
  "founders": [
    {
      "name": "Alex Federation, Founder",
      "description": "I'm the co-founder of Talus Bio. Prior to Talus, I trained with Jay Bradner at Harvard in medicinal chemistry, drug screening, and drug development for gene regulators. After that, I moved to Seattle to continue my training in epigenomics and proteomics, and these were all combined to develop the Talus gene regulator platform.",
      "linkedin": "https://www.linkedin.com/in/afederation/"
    },
    {
      "name": "Lindsay Pino, Founder",
      "description": "I'm Talus Bio's CTO, where my focus is on developing techniques for quantitative proteomics and in particular the challenges associated with scaling-up quantitative proteomics experiments. I’ve trained at the Broad Institute, the University of Washington, and most recently the University of Pennsylvania.",
      "linkedin": "https://www.linkedin.com/in/lindsaykpino/"
    }
  ],
  "status": true,
  "markdown": "raw_markdown='[Skip to the content](https://www.talus.bio/<#qodef-page-content>)\\n[ ![logo main](https://talus.bio/wp-content/uploads/2023/04/tbl-dk.png)![logo dark](https://talus.bio/wp-content/uploads/2023/04/tbl-dk.png)![logo light](https://talus.bio/wp-content/uploads/2023/04/tbl-lt.png)](https://www.talus.bio/<https:/talus.bio/>)\\n  * [](https://www.talus.bio/<https:/talus.bio/>)\\n  * [About Us](https://www.talus.bio/<https:/talus.bio/about-us/>)\\n  * [Our Technology](https://www.talus.bio/<https:/talus.bio/our-technology/>)\\n  * [Pipeline](https://www.talus.bio/<https:/talus.bio/pipeline/>)\\n  * [News & Publications](https://www.talus.bio/<https:/talus.bio/news-publications/>)\\n  * [Careers](https://www.talus.bio/<https:/talus.bio/careers/>)\\n  * [Contact](https://www.talus.bio/<https:/talus.bio/contact/>)\\n\\n\\n[ ![logo main](https://talus.bio/wp-content/uploads/2023/04/tbl-dk.png)](https://www.talus.bio/<https:/talus.bio/>) [ ](https://www.talus.bio/<javascript:void\\\\(0\\\\)>)\\n  * [Home](https://www.talus.bio/<https:/talus.bio/>)\\n  * [About Us](https://www.talus.bio/<https:/talus.bio/about-us/>)\\n  * [Our Technology](https://www.talus.bio/<https:/talus.bio/our-technology/>)\\n  * [Pipeline](https://www.talus.bio/<https:/talus.bio/pipeline/>)\\n  * [News & Publications](https://www.talus.bio/<https:/talus.bio/news-publications/>)\\n  * [Careers](https://www.talus.bio/<https:/talus.bio/careers/>)\\n  * [Contact](https://www.talus.bio/<https:/talus.bio/contact/>)\\n\\n\\n![Parallax Image](https://talus.bio/wp-content/uploads/2023/08/shutterstock_406955839.jpg)\\n# The new frontier in transcription factor drug discovery\\nMARMOT is the first platform to target previously “undruggable” transcription factors in their native cellular environments. \\n![](https://talus.bio/wp-content/uploads/2023/08/ss_1125191711.jpg)\\n##  Enabling and accelerating drug development for the most challenging therapeutic targets \\nTranscription factor drugs hold immense potential to treat diseases like cancer, diabetes, and more... Yet only a handful of transcription factors have approved drugs today.\\n[ Explore MARMOT](https://www.talus.bio/<https:/talus.bio/our-technology/>)\\n##  Talus Bioscience combines functional proteomics, automated biology, and machine learning to target these hard-to-treat transcription factor proteins driving cancer and beyond \\n![Talus Bio](https://talus.bio/wp-content/uploads/2023/08/7523_talusbio-GHC-158-1100x1000.jpg)\\n##  News & Updates \\n[ ![](https://talus.bio/wp-content/uploads/2025/01/Eqvista-Website-Update-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####  [ Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Drugging-the-Undruggable_The-case-for-open-source-scientific-software-2-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####  [ Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Talus-Bio-VP-of-BD-Website-Image-Updated-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####  [ Talus Bioscience Announces New VP of Business Development Chris Joyce ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Lindsay-HUPO-Award-Oct-2024-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####  [ Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n[ ![](https://talus.bio/wp-content/uploads/2025/01/Eqvista-Website-Update-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####  [ Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Drugging-the-Undruggable_The-case-for-open-source-scientific-software-2-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####  [ Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Talus-Bio-VP-of-BD-Website-Image-Updated-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####  [ Talus Bioscience Announces New VP of Business Development Chris Joyce ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Lindsay-HUPO-Award-Oct-2024-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####  [ Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n[ ![](https://talus.bio/wp-content/uploads/2025/01/Eqvista-Website-Update-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####  [ Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Drugging-the-Undruggable_The-case-for-open-source-scientific-software-2-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####  [ Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Talus-Bio-VP-of-BD-Website-Image-Updated-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####  [ Talus Bioscience Announces New VP of Business Development Chris Joyce ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n[ ![](https://talus.bio/wp-content/uploads/2024/12/Lindsay-HUPO-Award-Oct-2024-1300x650.jpg) ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####  [ Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n[ ![Boom Capital](https://talus.bio/wp-content/uploads/2022/10/bcl.png) ](https://www.talus.bio/<#>) ![FundersClub](https://talus.bio/wp-content/uploads/2023/08/ff2.png) ![Pioneer Fund](https://talus.bio/wp-content/uploads/2023/08/pf-logo.jpeg) ![BoxOne Ventures](https://talus.bio/wp-content/uploads/2023/08/bo-logo.png) [ ![50y](https://talus.bio/wp-content/uploads/2022/10/50y-logo.png) ](https://www.talus.bio/<#>) [ ![nfx](https://talus.bio/wp-content/uploads/2022/10/nfx-Logo.jpeg) ](https://www.talus.bio/<#>) [ ![YFX](https://talus.bio/wp-content/uploads/2022/10/YFX-logo.png) ](https://www.talus.bio/<#>) [ ![Boom Capital](https://talus.bio/wp-content/uploads/2022/10/bcl.png) ](https://www.talus.bio/<#>) ![FundersClub](https://talus.bio/wp-content/uploads/2023/08/ff2.png) ![Pioneer Fund](https://talus.bio/wp-content/uploads/2023/08/pf-logo.jpeg) ![BoxOne Ventures](https://talus.bio/wp-content/uploads/2023/08/bo-logo.png) [ ![50y](https://talus.bio/wp-content/uploads/2022/10/50y-logo.png) ](https://www.talus.bio/<#>) [ ![nfx](https://talus.bio/wp-content/uploads/2022/10/nfx-Logo.jpeg) ](https://www.talus.bio/<#>) [ ![YFX](https://talus.bio/wp-content/uploads/2022/10/YFX-logo.png) ](https://www.talus.bio/<#>) [ ![Boom Capital](https://talus.bio/wp-content/uploads/2022/10/bcl.png) ](https://www.talus.bio/<#>)\\n![Talus Bioscience](https://talus.bio/wp-content/uploads/2023/04/tbl-lt-300x95.png) Nothing is undruggable\\n[ ](https://www.talus.bio/<https:/twitter.com/talusbio>)\\n[ ](https://www.talus.bio/<https:/www.linkedin.com/company/talus-bio/>)\\nCompany\\n  * [About Us](https://www.talus.bio/<https:/talus.bio/about-us/>)\\n  * [Our Team](https://www.talus.bio/<https:/talus.bio/our-team/>)\\n  * [News & Publications](https://www.talus.bio/<https:/talus.bio/news-publications/>)\\n  * [Careers](https://www.talus.bio/<https:/talus.bio/careers/>)\\n  * [Contact Us](https://www.talus.bio/<https:/talus.bio/contact/>)\\n\\n\\nTalus Bioscience, Inc.\\n  * [550 17th AveSuite 550Seattle, WA 98122](https://www.talus.bio/<https:/goo.gl/maps/GN4RFbFLFakPR9f4A?coh=178571&entry=tt>)\\n  * info@talus.bio\\n  * [(206) 487-1062](https://www.talus.bio/<tel:12064871062>)\\n\\n\\nCopyright © Talus Bioscience. All Rights Reserved. Creative: [Contact Designers](https://www.talus.bio/<https:/www.contactdesigners.com>).\\n[Financial Conflicts of Interest Policy](https://www.talus.bio/<https:/talus.bio/wp-content/uploads/2023/07/FCOIPolicy.pdf>)\\n[ Back to top  ](https://www.talus.bio/<#>) Drag \\n' markdown_with_citations='Skip to the content⟨1⟩\\n ![logo main⟨2⟩![logo dark⟨2⟩]![logo light⟨3⟩]](https://www.talus.bio/<https:/talus.bio/>)\\n  * [](https://www.talus.bio/<https:/talus.bio/>)\\n  * About Us⟨4⟩\\n  * Our Technology⟨5⟩\\n  * Pipeline⟨6⟩\\n  * News & Publications⟨7⟩\\n  * Careers⟨8⟩\\n  * Contact⟨9⟩\\n\\n\\n ![logo main⟨2⟩](https://www.talus.bio/<https:/talus.bio/>)  ⟨10⟩>)\\n  * Home⟨11⟩\\n  * About Us⟨4⟩\\n  * Our Technology⟨5⟩\\n  * Pipeline⟨6⟩\\n  * News & Publications⟨7⟩\\n  * Careers⟨8⟩\\n  * Contact⟨9⟩\\n\\n\\n![Parallax Image⟨12⟩]\\n# The new frontier in transcription factor drug discovery\\nMARMOT is the first platform to target previously “undruggable” transcription factors in their native cellular environments. \\n![](https://talus.bio/wp-content/uploads/2023/08/ss_1125191711.jpg)\\n##  Enabling and accelerating drug development for the most challenging therapeutic targets \\nTranscription factor drugs hold immense potential to treat diseases like cancer, diabetes, and more... Yet only a handful of transcription factors have approved drugs today.\\n Explore MARMOT⟨5⟩\\n##  Talus Bioscience combines functional proteomics, automated biology, and machine learning to target these hard-to-treat transcription factor proteins driving cancer and beyond \\n![Talus Bio⟨13⟩]\\n##  News & Updates \\n ![⟨14⟩ ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####   Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ⟨15⟩\\n ![⟨16⟩ ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####   Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ⟨17⟩\\n ![⟨18⟩ ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####   Talus Bioscience Announces New VP of Business Development Chris Joyce ⟨19⟩\\n ![⟨20⟩ ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####   Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ⟨21⟩\\n ![⟨14⟩ ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####   Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ⟨15⟩\\n ![⟨16⟩ ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####   Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ⟨17⟩\\n ![⟨18⟩ ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####   Talus Bioscience Announces New VP of Business Development Chris Joyce ⟨19⟩\\n ![⟨20⟩ ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####   Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ⟨21⟩\\n ![⟨14⟩ ](https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>)\\n#####   Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series ⟨15⟩\\n ![⟨16⟩ ](https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>)\\n#####   Introducing Drugging the Undruggable, a New Blog Series from Talus Bio ⟨17⟩\\n ![⟨18⟩ ](https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>)\\n#####   Talus Bioscience Announces New VP of Business Development Chris Joyce ⟨19⟩\\n ![⟨20⟩ ](https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>)\\n#####   Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino ⟨21⟩\\n ![Boom Capital⟨22⟩ ](https://www.talus.bio/<#>) ![FundersClub⟨23⟩] ![Pioneer Fund⟨24⟩] ![BoxOne Ventures⟨25⟩]  ![50y⟨26⟩ ](https://www.talus.bio/<#>)  ![nfx⟨27⟩ ](https://www.talus.bio/<#>)  ![YFX⟨28⟩ ](https://www.talus.bio/<#>)  ![Boom Capital⟨22⟩ ](https://www.talus.bio/<#>) ![FundersClub⟨23⟩] ![Pioneer Fund⟨24⟩] ![BoxOne Ventures⟨25⟩]  ![50y⟨26⟩ ](https://www.talus.bio/<#>)  ![nfx⟨27⟩ ](https://www.talus.bio/<#>)  ![YFX⟨28⟩ ](https://www.talus.bio/<#>)  ![Boom Capital⟨22⟩ ](https://www.talus.bio/<#>)\\n![Talus Bioscience⟨29⟩] Nothing is undruggable\\n ⟨30⟩\\n ⟨31⟩\\nCompany\\n  * About Us⟨4⟩\\n  * Our Team⟨32⟩\\n  * News & Publications⟨7⟩\\n  * Careers⟨8⟩\\n  * Contact Us⟨9⟩\\n\\n\\nTalus Bioscience, Inc.\\n  * 550 17th AveSuite 550Seattle, WA 98122⟨33⟩\\n  * info@talus.bio\\n  * (206) 487-1062⟨34⟩\\n\\n\\nCopyright © Talus Bioscience. All Rights Reserved. Creative: Contact Designers⟨35⟩.\\nFinancial Conflicts of Interest Policy⟨36⟩\\n Back to top  ⟨37⟩ Drag \\n' references_markdown='\\n\\n## References\\n\\n⟨1⟩ https://www.talus.bio/<#qodef-page-content>: Skip to the content\\n⟨2⟩ https://talus.bio/wp-content/uploads/2023/04/tbl-dk.png:  ![logo main\\n⟨3⟩ https://talus.bio/wp-content/uploads/2023/04/tbl-lt.png: logo light\\n⟨4⟩ https://www.talus.bio/<https:/talus.bio/about-us/>: About Us\\n⟨5⟩ https://www.talus.bio/<https:/talus.bio/our-technology/>: Our Technology\\n⟨6⟩ https://www.talus.bio/<https:/talus.bio/pipeline/>: Pipeline\\n⟨7⟩ https://www.talus.bio/<https:/talus.bio/news-publications/>: News & Publications\\n⟨8⟩ https://www.talus.bio/<https:/talus.bio/careers/>: Careers\\n⟨9⟩ https://www.talus.bio/<https:/talus.bio/contact/>: Contact\\n⟨10⟩ https://www.talus.bio/<javascript:void\\\\(0\\\\:  \\n⟨11⟩ https://www.talus.bio/<https:/talus.bio/>: Home\\n⟨12⟩ https://talus.bio/wp-content/uploads/2023/08/shutterstock_406955839.jpg: Parallax Image\\n⟨13⟩ https://talus.bio/wp-content/uploads/2023/08/7523_talusbio-GHC-158-1100x1000.jpg: Talus Bio\\n⟨14⟩ https://talus.bio/wp-content/uploads/2025/01/Eqvista-Website-Update-1300x650.jpg:  ![\\n⟨15⟩ https://www.talus.bio/<https:/talus.bio/eqvista-profiles-talus-bio-ceo-in-its-founder-spotlight-interview-series/>:  Eqvista Profiles Talus Bio CEO in its Founder Spotlight Interview Series \\n⟨16⟩ https://talus.bio/wp-content/uploads/2024/12/Drugging-the-Undruggable_The-case-for-open-source-scientific-software-2-1300x650.jpg:  ![\\n⟨17⟩ https://www.talus.bio/<https:/talus.bio/introducing-drugging-the-undruggable-a-new-blog-series-from-talus-bio/>:  Introducing Drugging the Undruggable, a New Blog Series from Talus Bio \\n⟨18⟩ https://talus.bio/wp-content/uploads/2024/12/Talus-Bio-VP-of-BD-Website-Image-Updated-1300x650.jpg:  ![\\n⟨19⟩ https://www.talus.bio/<https:/talus.bio/talus-bioscience-announces-new-vp-of-business-development-chris-joyce/>:  Talus Bioscience Announces New VP of Business Development Chris Joyce \\n⟨20⟩ https://talus.bio/wp-content/uploads/2024/12/Lindsay-HUPO-Award-Oct-2024-1300x650.jpg:  ![\\n⟨21⟩ https://www.talus.bio/<https:/talus.bio/human-proteome-organization-honors-co-founder-and-cto-lindsay-pino/>:  Human Proteome Organization Honors Co-Founder and CTO Lindsay Pino \\n⟨22⟩ https://talus.bio/wp-content/uploads/2022/10/bcl.png:  ![Boom Capital\\n⟨23⟩ https://talus.bio/wp-content/uploads/2023/08/ff2.png: FundersClub\\n⟨24⟩ https://talus.bio/wp-content/uploads/2023/08/pf-logo.jpeg: Pioneer Fund\\n⟨25⟩ https://talus.bio/wp-content/uploads/2023/08/bo-logo.png: BoxOne Ventures\\n⟨26⟩ https://talus.bio/wp-content/uploads/2022/10/50y-logo.png:  ![50y\\n⟨27⟩ https://talus.bio/wp-content/uploads/2022/10/nfx-Logo.jpeg:  ![nfx\\n⟨28⟩ https://talus.bio/wp-content/uploads/2022/10/YFX-logo.png:  ![YFX\\n⟨29⟩ https://talus.bio/wp-content/uploads/2023/04/tbl-lt-300x95.png: Talus Bioscience\\n⟨30⟩ https://www.talus.bio/<https:/twitter.com/talusbio>:  \\n⟨31⟩ https://www.talus.bio/<https:/www.linkedin.com/company/talus-bio/>:  \\n⟨32⟩ https://www.talus.bio/<https:/talus.bio/our-team/>: Our Team\\n⟨33⟩ https://www.talus.bio/<https:/goo.gl/maps/GN4RFbFLFakPR9f4A?coh=178571&entry=tt>: 550 17th AveSuite 550Seattle, WA 98122\\n⟨34⟩ https://www.talus.bio/<tel:12064871062>: (206) 487-1062\\n⟨35⟩ https://www.talus.bio/<https:/www.contactdesigners.com>: Contact Designers\\n⟨36⟩ https://www.talus.bio/<https:/talus.bio/wp-content/uploads/2023/07/FCOIPolicy.pdf>: Financial Conflicts of Interest Policy\\n⟨37⟩ https://www.talus.bio/<#>:  Back to top  \\n' fit_markdown='' fit_html=''",
  "generated_description": "**Company Overview: Talus Bio**\n\nFounded in 2020 and located in Seattle, WA, Talus Bio is at the forefront of biotechnology, specifically focused on drug discovery that targets the DNA regulome—essentially, the regulatory elements of our genome. With a mission to reinvent how we approach “undruggable” genomic regulators, Talus Bio has effectively moved drug discovery from artificial environments back into living human cells. This method ensures that the functions of regulome proteins are accurately assessed, enabling a deeper understanding of how drugs can modify their actions.\n\n**Technology and Innovations**\n\nTalus Bio has developed an impressive platform called MARMOT, which stands out for its ability to target previously \"undruggable\" transcription factors in their native cellular contexts. By combining cutting-edge automated cell processing, next-gen proteomics, and advanced data analytics, the platform can evaluate a drug's impact on the entire regulome within a single experiment. This is particularly significant for addressing complex diseases like cancer and diabetes, where therapeutic options are often limited.\n\n**Team and Ecosystem**\n\nThe Talus Bio team consists of 16 employees who are dedicated to pushing the boundaries of drug development in challenging therapeutic areas. They were also a part of the Y Combinator Batch S21, which is a testament to their innovative approach and potential for growth. Jared Friedman serves as their Group Partner, providing strategic guidance.\n\n**Current Initiatives and Community Engagement**\n\nOn their website, you can explore various sections detailing their technology, research pipeline, and recent publications. They also share updates on staffing changes and new initiatives, including a blog that addresses drugging the undruggable. By fostering a culture of openness and innovation, Talus Bio aims to bridge gaps in the healthcare landscape, so no target feels insurmountable.\n\nTo learn more about their technology and vision, visit their website at [Talus Bio](https://www.talus.bio). \n\nIn the grand scheme, what Talus Bio is doing is not just about creating drugs—it's challenging the very notion of what's possible in biotechnology. With the right tools and mindset, they believe that nothing is truly \"undruggable.\""
}